Filter by: patients
Home > Community Treatment Reports and Side Effects > Intravenous Immuno Globulin IVIg Treatment Report
What is Intravenous Immuno Globulin IVIg?

Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immunodeficiency disorders, B-cell chronic lymphocytic leukemia, inflammatory demyelinating disorders. Off label uses include Guillain-Barré, Multiple Sclerosis, and myasthenia gravis.

Reported Side Effects

Side effects as an overall problem

Severe
 4
Moderate
 14
Mild
 17
None
 24

Commonly reported side effects, conditions, and hospitalizations associated with Intravenous Immuno Globulin IVIg

Headaches 19
Hospitalization 4
Weight gain 4
Tiredness 2
Nausea 2
Shortness of breath (dyspnea) 2
See all 28 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Intravenous Immuno Globulin IVIg. See all 62 dosages ►

  0.5 g monthly 5 g monthly 10 g monthly 10 g every other week 25 g monthly 30 mg monthly 30 g monthly 40 g monthly 50 g monthly 60 g every other week
  2 Number of Patients: 2 5 Number of Patients: 5 12 Number of Patients: 12 3 Number of Patients: 3 4 Number of Patients: 4 3 Number of Patients: 3 3 Number of Patients: 3 4 Number of Patients: 4 2 Number of Patients: 2 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Intravenous Immuno Globulin IVIg (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 45   Did not seem to work: 38%
Course of treatment ended 36   Course of treatment ended: 30%
Doctor's advice 36   Doctor's advice: 30%
Other 20   Other: 17%
Side effects too severe 17   Side effects too severe: 14%
Expense 7   Expense: 6%
Change in health plan coverage 4   Change in health plan coverage: 3%
Personal research 2   Personal research: 2%
Not indicated 1   Not indicated: 1%

See all 114 patients who’ve stopped taking Intravenous Immuno Globulin IVIg

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Intravenous Immuno Globulin IVIg

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Intravenous Immuno Globulin IVIg

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Intravenous Immuno Globulin IVIg

Always
 55 93%
Usually
 1 2%
Sometimes
 1 2%
Never
 2 3%

Burden

Difficulty being on treatment

Burden of Intravenous Immuno Globulin IVIg

Very
 5 8%
Somewhat
 20 34%
A little
 18 31%
Not at all
 16 27%

Cost

Paid out of pocket

Cost of Intravenous Immuno Globulin IVIg

$200+
 9 27%
$100-199
 1 3%
$50-99
 0 0%
$25-49
 4 12%
< $25
 18 55%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 25, 2012.